Archimed Group Plans to Conduct a Second Tender Offer for Jeisys Medical
In the first tender offer, 42.5 million shares of Jeisys Medical were purchased by Archimed Group. Post tender offer, Archimed now owns an 82.1% stake in Jeisys Medical.
On 24 July, it was announced that Archimed will be conducting a second tender offer for Jeisys Medical. The second tender offer will be made for 17.2% of common shares.
It could be difficult for Archimed to gain more than 95% stake at the end of the second tender offer. Rather, a third tender offer is likely in 2025.
Results of the First Tender Offer
Prior to the tender offer, Archimed Group (Syracuse SubCo Inc) owned 20,458,918 shares (26.7% stake) of Jeisys Medical (287410 KS). There were 42,499,191 shares (55.4% stake) that were tendered. Therefore, Archimed Group (Syracuse SubCo Inc) now owns an 82.1% stake in Jeisys Medical. Archimed spent 552.5 billion won to acquire an additional 55.4% stake in Jeisys Medical in this first tender offer.
Keep reading with a 7-day free trial
Subscribe to Douglas Research Insights to keep reading this post and get 7 days of free access to the full post archives.